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Chapter 47
Environmental Burden of Diseases
Otto Ha¨nninen
Abstract Environmental exposures are associated with a large variety of human
diseases ranging from headaches and annoyance to cancer and premature death.
Comparison of such risks and prioritization of preventive measures therefore
cannot be based on incidence or prevalence rates. Environmental burden of disease
methodology, developed by World Health Organization, accounts for both years of
life lost due to mortality as well as years lived with various disabilities. The latter
are quantified using, besides the duration of the condition, a severity weight. Such
weights are inherently value-loaded, but in practice the resulting environmental
burden of disease estimates have been found very useful.
Improved population health registries and harmonization of disease codes together
with statistical methods such as population attributable fraction that can be estimated
from epidemiological data, allow for rapid and comparable international assessments
as demonstrated e.g. by the Institute of Health Metrics and Evaluation.
Recent estimates suggest that fine particles (PM2.5) are the leading environ-
mental health risk in European countries by causing up to 10,000 non-discounted
lost years of health per million people annually in the EU.
Keywords Burden of disease • Health risk characterization • Population attribut-
able fraction • Disability adjusted life year • DALY
47.1 Introduction
Environmental indicators are designed to describe the state of the environment
and its impact on human beings, ecosystems and materials, the pressures on the
environment, and the driving forces and the responses steering the system. Indica-
tors have gone through a selection and often an aggregation process to enable them
to steer action (EEA 2012). First order environmental indicators focus on the state
of the environment. However, comparison of the importance of the state descriptors
across a wide range of indicators is not directly supported. Therefore, a second
order of indicators is needed to translate the state into the magnitude of impacts.
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This section of the book covers indicators that focus on impacts on human beings
and especially on population health. This is achieved by combining information on
the state of the environment, determining the population exposures to risk factors,
with population characteristics, including age and gender distributions and health
status, to generate a ranking of environmental stressors based on their population
health importance. One of these approaches is called environmental burden of
disease (EBD) and is the topic of this chapter.
47.2 Background
Prevention and control of disease and injury require information about the leading
medical causes of illness and the associated exposures and risk factors (Murray and
Lopez 1997). Assessment of the public-health importance of various risk factors
involves comparisons of highly variable health conditions ranging from relatively
mild diseases, such as the common cold or sleep disturbance, to serious life
threatening and fatal conditions. Up to the 1990s, mortality statistics were used as
a crude metric for serious health hazards and they have served quite well over the
decades for tackling the most important causes of death. However, mortality counts
can hardly be compared with less severe outcomes when investigating the overall
burden over a wide range of diseases and risk factors.
The World Bank sponsored the first global burden of disease study in collabo-
ration with the World Health Organization (WHO) in 1993. As well as generating a
comprehensive and consistent set of estimates of mortality and morbidity by age,
sex and region for the world, the study also introduced a new metric to measure the
loss of health to quantify the burden of disease: disability adjusted life year (DALY)
(Mathers et al. 2004). Burden of disease (BoD), measured in DALYs, combines
health losses from premature mortality and from morbidity into a metric that allows
comparisons of the health losses due to a wide range of different causes, accounting
for morbidity as well as mortality. Moreover, also the quantification of deaths is
enhanced from body counts to quantify the years of life lost due to mortality.
Figure 47.1 depicts some examples of disability weighted health conditions.
47.3 Methods
Burden of disease is a measure of sickness and death in a population. The burden of
disease methodology is based on making years lived with a disability (YLD)
comparable with years of life lost (YLL) due to premature mortality. Summing
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these two components produces disability adjusted life years (DALY) (Murray and
Lopez 1997):
BoD ¼ YLLþ YLD ð47:1Þ
Years of life lost (YLL) in a case of premature mortality are calculated as the
age-specific remaining life expectancy at the age of death. Mortality numbers, ages
of death by causes, incidences of acute and chronic diseases and corresponding
mean durations available in health registries are supplemented with disability
weights.
Disabilities caused by various types of diseases are calculated by accounting for
both the duration of the disease (L ) and the disease severity expressed as a disease
specific disability weight (DW):
YLD ¼ DW  L ð47:2Þ
The value of the time lived in non-fatal health states, in comparison with life lost
due to premature mortality, is estimated using health state weights reflecting social
preferences for different states of health.
Although the disability weights used in DALY calculations quantify societal
preferences for different health states, the weights do not represent the lived experi-
ence of any disability or health state, or imply any societal value for the person in a
disability or health state. Rather, they quantify societal preferences for health states in
relation to the societal ideal of good health. The term “disability” is used broadly to
refer to departures from good or ideal health in any of the important domains of
health. These include mobility, self-care, participation in usual activities, pain and
discomfort, anxiety and depression, and cognitive impairment (Pru¨ss-U¨stu¨n
et al. 2003). Examples of disability weight values, collected from dedicated
Fig. 47.1 Examples of disability adjusted life-year losses due to various diseases (grey areas)
(Modified from de Hollander et al. 1999)
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questionnaire panels, are shown in Table 47.1. Treatment of diseases further modifies
the diseases and the disabilities. In many cases a treated disease is substantially less
disabling than a non-treated disease. These differences are highlighted in the table,
too. More data on disability weights can be found in Opasnet 2014.
47.4 Population Attributable Fractions
In practice, burden of disease estimates describe the overall burden in a population
and generally only a small fraction of this is attributable to given environmental and
other risk factors.
Table 47.1 Examples of disability weights (Adopted from Murray and Lopez 1996)
Disability weight
Disease Untreated disease Treated disease
AIDS 0.50 0.50
Infertility 0.18 0.18
Diarrhoea disease, episodes 0.11 0.11
Measles episode 0.15 0.15
Tuberculosis 0.27 0.27
Malaria, episodes 0.20 0.20
Trachoma, blindness 0.60 0.49
Trachoma, low vision 0.24 0.24
Lower respiratory tract infection, episodes 0.28 0.28
Lower respiratory tract infection, chronic 0.01 0.01
Cancers, terminal stage 0.81 0.81
Diabetes mellitus cases (uncomplicated) 0.01 0.03
Unipolar major depression, episodes 0.60 0.30
Alcohol dependence syndrome 0.18 0.18
Parkinson disease cases 0.39 0.32
Alzheimer disease cases 0.64 0.64
Post-traumatic stress disorder 0.11 0.11
Angina pectoris 0.23 0.10
Congestive heart failure 0.32 0.17
Chronic obstructive lung disease, symptoma 0.43 0.39
Asthma, cases 0.10 0.06
Deafness 0.22 0.17
Benign prostatic hypertrophy 0.04 0.04
Osteoarthritis, symptomatic hip or knee 0.16 0.11
Brain injury, long-term sequelae 0.41 0.35
Spinal cord injury 0.73 0.73
Sprains 0.06 0.06
Burns (>60 %) – long term 0.25 0.25
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Burden of disease can be estimated using a bottom-up approach described in
Eqs. 47.1 and 47.2. However, the mathematical properties of relative risks offer a
lucratively easy way to estimate the fraction of disease burden associated with a
given risk factor when epidemiological data are available. In 1953, Levin first
proposed the concept of the population attributable fraction. Since then, the phrases
“population attributable risk,” “population attributable risk proportion,” “excess
fraction,” and “etiologic fraction” have been used interchangeably to refer to the
proportion of disease risk in a population that can be attributed to the causal effects
of a risk factor or set of factors (Rockhill et al. 1998).
In this context, the environmental burden of disease associated with a given risk
factor can be calculated simply from the overall population burden of a given
disease by multiplying it by the epidemiological estimate of the population attrib-
utable fraction. National background burden of disease data are directly available
from the World Health Organization (2013).
EBD ¼ PAF BoD ð47:3Þ
As described in more detail in Ha¨nninen and Knol (2011), the population
attributable fraction (PAF) can be derived from relative risk (RR) as
PAF ¼ f  RR 1ð Þ
f  RR 1ð Þ þ 1 ð47:4Þ
where f is the fraction of population exposed to a given factor and RR is the relative
risk of the exposed population.
In the case of environmental exposures, the relative risk is commonly expressed
per a standard increment of exposures, e.g., 10 μg m3 as in the case of fine particles
(in this case, exposure to e.g., 15 μg m3 would be expressed as E¼ 1.5). The
needed relative risk at the current exposure level can be directly calculated as
RR ¼ e ElnRRð Þ ¼ RRE ð47:5Þ
47.5 Assessments
Murray and Lopez (1997) developed the first global burden of disease study. At that
time, they considered two environmental risk factors: (i) poor water, sanitation, and
hygiene, and (ii) air pollution. In the updates of the global burden of disease project
for 2002 (World Health Report 2002) and 2004 (World Health Organization 2009),
additional environmental risk factors included: (iii) lead, (iv) indoor air pollution
from solid fuels, and (v) climate change.
One of the first more comprehensive analyses of environmental burden of
diseases from a number of risk factors was conducted by de Hollander
et al. (1999) in the Netherlands. The 19 environmental risk factors covered are
47 Environmental Burden of Diseases 849
Table 47.2 Estimated health impacts of selected environmental risk factors in the Netherlands
(Hollander et al. 1999), demonstrating that the population level health risks are dominated by a few
risk factors (particulate matter and accidents in this case)
Environmental
factor Included health end-points
Total
health
impact
Relative
contribution
(%)
DALY/
a/M
1 Particulate air pol-
lution (long-term
exposures)
Total and cardiopulmonary mortality,
lung cancer, chronic respiratory
symptoms in children, chronic bronchitis
15,482 52
2 Domestic accidents Hospital admissions, disability, mortality 6,390 21
3 Traffic accidents Hospital admissions, disability, mortality 4,640 16
4 Noise Severe annoyance, sleep disturbance 1,774 5.9
5 Lead (drinking-
water pipes)
469 1.6
6 Foodborne Acute gastroenteritis, symptoms and
mortality
266 0.89
7 ETS Lung cancer and ischemic heart disease
mortality and morbidity, asthma aggra-
vation, lower respiratory tract symptoms,
otitis media, sudden infant death
262 0.88
8 Particulate air pol-
lution (short-term
exposures)
Respiratory, coronary heart disease,
pneumonia, and other mortality,
respiratory and cardiovascular hospital
admissions, respiratory emergency room
visits, asthmatic attacks, use of broncho-
dilators, upper and lower respiratory tract
symptoms
172 0.58
9 Radon (indoor) Lung cancer mortality and morbidity 114 0.38
10 Damp houses Lower respiratory disease, asthma 109 0.37
11 Ozone air pollution Respiratory, cardiovascular, pneumonia,
and other mortality
87 0.29
12 UV-A/UV-B
exposure
Melanoma mortality and morbidity 30 0.10
13 B(a)P Respiratory disease hospital admissions
and emergency room visits
16 0.053
14 Benzene Leukemia mortality and morbidity 7.9 0.026
15 Large industrial
accidents
Mortality 1.3 0.0044
16 Vinyl chloride Hepatoangiosarcoma mortality and
morbidity
0.79 0.0027
17 Ethylene oxide Leukemia mortality and morbidity 0.11 0.0004
18 1,2-Dichloroethane Cancer mortality and morbidity 0.10 0.0003
19 Acrylonitrile Lung cancer mortality and morbidity 0.09 0.0003
Total 29,821 100
listed in Table 47.2, with a leading contribution from long-term exposures to
ambient particulate matter and domestic and traffic accidents. These results
demonstrated that, while environmental concerns are presented regarding a large
number of pollutants, the public health impacts are driven by a relatively small
number of factors and that these factors may not receive as much attention as the
disease burden associated with them would justify.
47.6 WHO Environmental Burden of Disease Programme
World Health Organization Headquarters in Geneva has continued to promote
the environmental burden of disease methodologies actively for more than a
decade. As part of their activities, they continue pushing the methodologies forward
in the Environmental Burden of Disease series, with the latest contributions
for inadequate housing (WHO 2011a) and environmental noise (WHO 2011b).
These and other related WHO reports are available at http://www.who.int/quantify
ing_ehimpacts/publications/en/.
47.7 European EBoDE -Study
A more recent approach compared the environmental burden of disease over six
European countries. The EBoDE-study (Ha¨nninen and Knol 2011; Ha¨nninen
et al. 2014) covered nine environmental risk factors based on their presumed public
health impact (e.g., particulate matter, second hand smoke, radon, traffic noise),
individual high risk (several carcinogens), public concern (e.g., benzene, dioxins),
and economic values (e.g., formaldehyde).
The overall annual environmental burden of disease was estimated to be 11,324
DALY/million, or 2.6 million DALY in total in the participating six countries. Fine
particles were by far the dominating source of burden (Fig. 47.2), followed by
second hand smoke, traffic noise, and radon. Fine particles were the leading cause
in all countries, but the order of the following factors varied between countries due
to the national conditions. E.g., in Finland, radon was the second most important
factor due to the relatively high occurrence of uranium in the soil, producing radon
in the radiological decay chain. In contrast, Finland had clearly the lowest impacts
from second hand smoke due to proactive tobacco legislation already developed in
the 1970s (Ha¨nninen and Knol 2011; Ha¨nninen et al. 2014).
Finland also had the highest formaldehyde exposures, but the associated health
impacts were estimated to be almost negligible. However, formaldehyde very well
demonstrates the various magnitudes of uncertainties in the estimates. Formalde-
hyde has been shown to be carcinogenic in occupational settings, where exposure
levels range from 2 to 5 mg m3. However, later systematic reviews by WHO and
others on studies in general populations rarely exposed to over 100 μg m3 have
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concluded that nasal carcinogenic risk occurs only at substantially higher expo-
sures, such as in occupational settings. Thus, the formaldehyde estimate did not
include cancer as an outcome.
Uncertainties of the various environmental burden of disease estimates were
evaluated in an expert panel, supported by a number of quantitative simulations of
model and parameter uncertainties. Uncertainties for stressors like fine particles, for
which the estimates were based on epidemiological data from large real populations
at existing range of exposures were considered the smallest (Table 47.3). Pollutants
for which even the selection of health end points contained substantial uncer-
tainties, such as dioxins and formaldehyde, were classified as having the lowest
certainty of the overall assessment.
More recently, environmental burden of disease methodology has been applied
specifically to exposures in indoor spaces. Logue et al. (2012) combined the
methodology with toxicological estimation of the dose-response coefficients.
While the uncertainties of such estimates are much wider than when using epide-
miological data, their results provided fresh insights into significant pollutants
potentially missing from previous estimates, including acrolein, ozone, and acetal-
dehyde. Ha¨nninen and Asikainen (2013) refined a similar assessment toward
evaluating the effectiveness of ventilation and other risk management actions.
They found that ventilation alone is not capable of reducing the burden much.
However, combining ventilation with filtration of intake air and indoor source
controls, over two million DALY could be saved annually in the European Union.
One of the advantages of environmental burden of disease methodology is that it
can be readily used to compare also various endpoints against each other. Ha¨nninen
and Asikainen (2013) estimated the burden of disease of indoor exposures by
endpoints in 26 European countries (EU27 excluding Malta), showing that cardio-
vascular diseases dominate the total impacts (Fig. 47.3).
Fig. 47.2 Relative contributions of selected environmental factors on the environmental burden
of disease in six European countries (Ha¨nninen and Knol 2011; Ha¨nninen et al. 2014)
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47.8 Global Burden of Disease 2010 -Study
A recent major update of the global burden of disease study was coordinated by
the Seattle-based Institute of Health Metrics, funded by the Bill Gates Foundation
and published in a special issue of Lancet in December 2012. Lim et al. (2012)
investigated the national and continental risks of 67 risk factors, now adding
Table 47.3 Relative uncertainties in the EBoDE estimates (Ha¨nninen and Knol 2011; Ha¨nninen
et al. 2014)
Uncertainty
level Stressor Sources of uncertainties
High Dioxins Endpoint uncertainty (total cancer)
Formaldehyde Endpoint uncertainty (limited evidence on asthma)
Medium Traffic noise Exposure data from early phase of European Noise Directive
data collection
Lead Limited exposure data since abandoning tetraethyl lead additive
Ozone Loss of life uncertain (1 year assumed per death)
Low PM2.5 Strong evidence from large number of epidemiological studies
in real human populationsSecond hand
smoke
Radon
Benzene
Fig. 47.3 Contribution of main disease categories to the burden of disease in EU26 caused by
indoor exposures to pollutants originating from outdoor (blue) and indoor (red) air (Ha¨nninen and
Asikainen 2013). The estimated maximum reduction is shown in the lighter shade by disease
category. COPD chronic obstructive pulmonary disease, CV cardiovascular diseases
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ambient ozone, residential radon, and a number of occupational risks to the palette
of previous GBD assessments. Important methodological updates included
dropping discounting and age weighting earlier used as a standard approach, and
switching from incidence-based assessment to prevalence, i.e., focusing on current
symptoms and not on the onset in the case of chronic diseases. The Institute for
Health Metrics also developed impressive web-based tools to browse the results
available at http://www.healthmetricsandevaluation.org/ numerically and
graphically.
47.9 Discounting and Age-Weighting
Interesting methodological details debated actively in the past include discounting
and age weighting. Originally Murray and Lopez (1996) used discounting to
estimate the economic present values of future assets, such as lost life years. In
the case of premature mortality, a substantial loss of life years may take place.
According to economic models, the present value of lost life years needs to be
adjusted by appropriate discounting. The World Health Organization adopted the
approach and used a 3 % annual discounting rate. The present value (pv) of a future
asset ( fv) obtained after n years, using a given discount rate, is calculated as
pv ¼ fv 1þ rateð Þn ð47:6Þ
In the case of multiple years of life lost, the cumulative sum of the present value
of lost future years (the future value of each being 1) can be calculated, marking
q¼ 1+ rate as the geometric sum:
cpv nð Þ ¼ 1 q
n
1 q ð47:7Þ
As an example, using a 3 % discount rate (rate¼ 0.03), a year of healthy life
gained 10 years from now is worth 24 % less than a year gained immediately.
Further, also an age weighing approach was developed by Murray (1996). BoD
calculations involve judgments about standard life expectancy, severity (disability)
weights, age weighting, and discounting over time. Murray (1996) also found
originally that a year of healthy life lived at younger and older ages was weighted
lower than that at middle age. In other words, Murray et al. chose to value a year of
life in young adulthood more than a year in old age or infancy. This choice was
based on a number of studies that have indicated there is a broad social preference
to value a year lived by a young adult more highly than a year lived by a young child
or at older ages (Fig. 47.4).
Both discounting and age weighting were heavily debated. For example,
children’s health has been given high priority in various international policies
(e.g., WHO 2010), contrasting the age weights applied. In addition, discounting
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leads to the fact that childhood mortality, leading to up to 70–80 life years lost, is
accounted for less than a similar amount of life years lost during a shorter period. As
a reaction to the criticism, the Global Burden 2010 study (Lim et al. 2012) decided
to drop both discounting and age weighting, giving equal values to the health of old
and young and life saved now or later.
Conclusions
Environmental burden of disease is a useful indicator to quantify the
population level health impacts of environmental factors, including chemical
pollutants and noise. It allows quantitative comparisons of public health
impacts associated with a wide range of environmental risk factors and
targeting research and especially risk management to the major issues.
However, the environmental burden of disease cannot directly be interpreted
as a reducible burden. In many cases, exposures to natural sources of pollu-
tion or the existence of overlapping risk factors lead to the fact that exposures
cannot be completely eliminated.
Further analysis may also be applicable for the cost effectiveness of
various risk management actions. In some cases, reduction in exposures
may require complex legislative changes as demonstrated, e.g., by removing
lead from fuels, water pipes, canned foods, paints, and so on, over the past
decades. Currently, similar challenges are being experienced, e.g., in control-
ling exposure to fine particles, which also have widely spread and have very
heterogeneous sources. However, combining environmental burden of
disease estimates with cost-effectiveness methodologies allows societies to
target their environmental control efforts as efficiently as possible.
Fig. 47.4 Weights shown for 1 DALY as function of loss age
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